These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 28716573

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Digital image analysis of pan-cytokeratin stained tumor slides for evaluation of tumor budding in pT1/pT2 colorectal cancer: Results of a feasibility study.
    Jepsen RK, Klarskov LL, Lippert MF, Novotny GW, Hansen TP, Christensen IJ, Høgdall E, Riis LB.
    Pathol Res Pract; 2018 Sep; 214(9):1273-1281. PubMed ID: 30017334
    [Abstract] [Full Text] [Related]

  • 24. HTRA3 is reduced in ovarian cancers regardless of stage.
    Zhao M, Ding JX, Nie GY, Wei J, Li Y, Yin XY, Chen Q.
    Cancer Invest; 2014 Nov; 32(9):464-9. PubMed ID: 25274382
    [Abstract] [Full Text] [Related]

  • 25. Periostin expression in intra-tumoral stromal cells is prognostic and predictive for colorectal carcinoma via creating a cancer-supportive niche.
    Xu X, Chang W, Yuan J, Han X, Tan X, Ding Y, Luo Y, Cai H, Liu Y, Gao X, Liu Q, Yu Y, Du Y, Wang H, Ma L, Wang J, Chen K, Ding Y, Fu C, Cao G.
    Oncotarget; 2016 Jan 05; 7(1):798-813. PubMed ID: 26556874
    [Abstract] [Full Text] [Related]

  • 26. Active immunosurveillance in the tumor microenvironment of colorectal cancer is associated with low frequency tumor budding and improved outcome.
    Koelzer VH, Dawson H, Andersson E, Karamitopoulou E, Masucci GV, Lugli A, Zlobec I.
    Transl Res; 2015 Aug 05; 166(2):207-17. PubMed ID: 25797890
    [Abstract] [Full Text] [Related]

  • 27. Tumour budding at invasive margins and outcome in colorectal cancer.
    Kanazawa H, Mitomi H, Nishiyama Y, Kishimoto I, Fukui N, Nakamura T, Watanabe M.
    Colorectal Dis; 2008 Jan 05; 10(1):41-7. PubMed ID: 18078460
    [Abstract] [Full Text] [Related]

  • 28. Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome.
    Weis CA, Kather JN, Melchers S, Al-Ahmdi H, Pollheimer MJ, Langner C, Gaiser T.
    Diagn Pathol; 2018 Aug 28; 13(1):64. PubMed ID: 30153844
    [Abstract] [Full Text] [Related]

  • 29. The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin.
    Xiao S, Liu L, Lu X, Long J, Zhou X, Fang M.
    J Cancer Res Clin Oncol; 2015 Aug 28; 141(8):1465-74. PubMed ID: 25716692
    [Abstract] [Full Text] [Related]

  • 30. The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome.
    Dawson H, Koelzer VH, Karamitopoulou E, Economou M, Hammer C, Muller DE, Lugli A, Zlobec I.
    Histopathology; 2014 Mar 28; 64(4):577-84. PubMed ID: 24111856
    [Abstract] [Full Text] [Related]

  • 31. Enrichment map profiling of the cancer invasion front suggests regulation of colorectal cancer progression by the bone morphogenetic protein antagonist, gremlin-1.
    Karagiannis GS, Berk A, Dimitromanolakis A, Diamandis EP.
    Mol Oncol; 2013 Aug 28; 7(4):826-39. PubMed ID: 23659962
    [Abstract] [Full Text] [Related]

  • 32. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C, Cai S, Wang X, Jiang Z.
    Oncotarget; 2015 Oct 06; 6(30):29324-34. PubMed ID: 26317553
    [Abstract] [Full Text] [Related]

  • 33. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors.
    Zlobec I, Lugli A.
    World J Gastroenterol; 2009 Dec 21; 15(47):5898-906. PubMed ID: 20014453
    [Abstract] [Full Text] [Related]

  • 34. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
    Koelzer VH, Huber B, Mele V, Iezzi G, Trippel M, Karamitopoulou E, Zlobec I, Lugli A.
    Hum Pathol; 2015 Nov 21; 46(11):1573-81. PubMed ID: 26351067
    [Abstract] [Full Text] [Related]

  • 35. Lysosomal acid phosphatase 2 is an unfavorable prognostic factor but is associated with better survival in stage II colorectal cancer patients receiving chemotherapy.
    Lee YC, Su CY, Lin YF, Lin CM, Fang CY, Lin YK, Hsiao M, Chen CL.
    Oncotarget; 2017 Feb 14; 8(7):12120-12132. PubMed ID: 28076332
    [Abstract] [Full Text] [Related]

  • 36. Identification and cloning of two isoforms of human high-temperature requirement factor A3 (HtrA3), characterization of its genomic structure and comparison of its tissue distribution with HtrA1 and HtrA2.
    Nie GY, Hampton A, Li Y, Findlay JK, Salamonsen LA.
    Biochem J; 2003 Apr 01; 371(Pt 1):39-48. PubMed ID: 12513693
    [Abstract] [Full Text] [Related]

  • 37. OASIS/CREB3L1 is epigenetically silenced in human bladder cancer facilitating tumor cell spreading and migration in vitro.
    Rose M, Schubert C, Dierichs L, Gaisa NT, Heer M, Heidenreich A, Knüchel R, Dahl E.
    Epigenetics; 2014 Dec 01; 9(12):1626-40. PubMed ID: 25625847
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of Tumor Budding in Primary Colorectal Cancer and Corresponding Liver Metastases Based on H&E and Pancytokeratin Staining.
    Blank A, Schenker C, Dawson H, Beldi G, Zlobec I, Lugli A.
    Front Med (Lausanne); 2019 Dec 01; 6():247. PubMed ID: 31737639
    [Abstract] [Full Text] [Related]

  • 39. Serine peptidase HTRA3 is closely associated with human placental development and is elevated in pregnancy serum.
    Nie G, Li Y, Hale K, Okada H, Manuelpillai U, Wallace EM, Salamonsen LA.
    Biol Reprod; 2006 Feb 01; 74(2):366-74. PubMed ID: 16251496
    [Abstract] [Full Text] [Related]

  • 40. Tyrosine kinase receptor B (TrkB) expression in colorectal cancers highlights anoikis resistance as a survival mechanism of tumour budding cells.
    Dawson H, Grundmann S, Koelzer VH, Galván JA, Kirsch R, Karamitopoulou E, Lugli A, Inderbitzin D, Zlobec I.
    Histopathology; 2015 Apr 01; 66(5):715-25. PubMed ID: 25382057
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.